Podcast: Non-binding Guidance: Breakthrough Devices Program
Podcast: Non-binding Guidance: Expedited Review Programs for Drugs and Biologics
On August 23, 2018, Dthera Sciences announced that the Food and Drug Administration granted Breakthrough Therapy designation to its Alzheimer’s disease therapeutic device. According to the FDA, Breakthrough Therapy...more